Evidera
Rajrupa Ghosh is a seasoned researcher specializing in epidemiology and real-world evidence. Currently serving as a Research Associate III at Evidera since January 2023, Rajrupa previously held a fellowship at the National Cancer Institute, leading significant studies on the therapeutic effects of tamoxifen in breast oncology. Academic experience includes a doctoral candidacy at the University of Maryland, where Rajrupa conducted influential research on phthalates and metabolic syndrome, contributing to peer-reviewed publications. A foundation in data analysis was established through roles at Harris County Public Health and the HealthPoint - Brazos Valley Community Action Agency, alongside substantial work as a Quality Manager for the West Bengal State AIDS Prevention and Control. Rajrupa holds a PhD in Epidemiology from the University of Maryland and a Master's degree in Epidemiology & Biostatistics from Texas A&M University.
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.